Question 1

What is the catalog number for P62 Dok, phosphorylated (Tyr398)?

Accepted Answer

The catalog number for P62 Dok, phosphorylated (Tyr398) is 403313.

Question 2

What sizes are available for P62 Dok, phosphorylated (Tyr398)?

Accepted Answer

P62 Dok, phosphorylated (Tyr398) is available in the following size(s): 50 µL, 100 µL.

Question 3

How many pack sizes does P62 Dok, phosphorylated (Tyr398) come in?

Accepted Answer

P62 Dok, phosphorylated (Tyr398) is available in 2 different pack sizes.

Question 4

Is P62 Dok, phosphorylated (Tyr398) in stock?

Accepted Answer

P62 Dok, phosphorylated (Tyr398) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

P62 Dok, phosphorylated (Tyr398)

Product Specifications

Clonality

Available Sizes

Frequently Asked Questions

Explore Other Products

4933436I01Rik Mouse Gene Knockout Kit (CRISPR)

Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/3284), CF740 conjugate, 0.1mg/mL

BAD Human Gene Knockout Kit (CRISPR)

CD47 (IAP/964 + B6H12.2), CF647 conjugate, 0.1mg/mL

Tissue FFPE Sections, Bone

Human KCTD21 activation kit by CRISPRa